Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $0.93 $185,500 - $325,500
-350,000 Reduced 24.7%
1,066,963 $618,000
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $441,000 - $797,999
-700,000 Reduced 33.07%
1,416,963 $1.18 Million
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $1.05 Million - $1.77 Million
-939,497 Reduced 30.74%
2,116,963 $2.39 Million
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $1.16 Million - $1.81 Million
-888,650 Reduced 22.53%
3,056,460 $4.89 Million
Q1 2023

May 15, 2023

SELL
$1.45 - $2.95 $1.37 Million - $2.79 Million
-945,762 Reduced 19.34%
3,945,110 $6 Million
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $807,216 - $1.3 Million
399,612 Added 8.9%
4,890,872 $11.7 Million
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $323,149 - $517,698
-164,872 Reduced 3.54%
4,491,260 $9.21 Million
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $5.27 Million - $10.7 Million
-4,050,000 Reduced 46.52%
4,656,132 $9.03 Million
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $940,000 - $1.39 Million
-400,000 Reduced 4.39%
8,706,132 $21.4 Million
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $967,109 - $1.9 Million
-331,202 Reduced 3.51%
9,106,132 $29.3 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $1.31 Million - $1.75 Million
263,752 Added 2.88%
9,437,334 $49.5 Million
Q2 2021

Aug 16, 2021

SELL
$2.56 - $5.49 $512,000 - $1.1 Million
-200,000 Reduced 2.13%
9,173,582 $50.4 Million
Q1 2021

May 17, 2021

SELL
$2.69 - $5.25 $6.67 Million - $13 Million
-2,478,790 Reduced 20.91%
9,373,582 $25.5 Million
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $4.07 Million - $5.76 Million
-1,282,528 Reduced 9.76%
11,852,372 $37.7 Million
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $19.1 Million - $33.3 Million
6,412,440 Added 95.39%
13,134,900 $52.5 Million
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $3.12 Million - $5.77 Million
1,361,593 Added 25.4%
6,722,460 $26.4 Million
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $4.97 Million - $11.4 Million
2,588,764 Added 93.39%
5,360,867 $13.1 Million
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $2.32 Million - $4.24 Million
963,807 Added 53.3%
2,772,103 $11.3 Million
Q3 2019

Nov 14, 2019

BUY
$2.17 - $3.14 $866,650 - $1.25 Million
399,378 Added 28.35%
1,808,296 $4.67 Million
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $126,499 - $152,000
50,000 Added 3.68%
1,408,918 $4.23 Million
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $223,588 - $374,054
-140,622 Reduced 9.38%
1,358,918 $3.23 Million
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $3.39 Million - $6.97 Million
1,499,540 New
1,499,540 $3.4 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.